KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Asset Utilization Ratio (2016 - 2026)

Edwards Lifesciences has reported Asset Utilization Ratio over the past 16 years, most recently at 0.45 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 7.65% year-over-year to 0.45; the TTM value through Dec 2025 reached 0.45, up 7.65%, while the annual FY2025 figure was 0.45, 6.52% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.45 at Edwards Lifesciences, up from 0.44 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.66 in Q2 2021 and troughed at 0.42 in Q4 2024.
  • A 5-year average of 0.53 and a median of 0.53 in 2022 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: dropped 27.74% in 2023 and later rose 9.12% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.63 in 2021, then decreased by 16.04% to 0.53 in 2022, then increased by 1.43% to 0.53 in 2023, then dropped by 21.85% to 0.42 in 2024, then grew by 7.65% to 0.45 in 2025.
  • Business Quant data shows Asset Utilization Ratio for EW at 0.45 in Q4 2025, 0.44 in Q3 2025, and 0.43 in Q2 2025.